国产精品久久久久久永久牛牛,55国产福利在线视频,成人午夜精品视频在线观看

至今，GenScript的服務及產品已被Cell, Nature, Science, PNAS等1300多家生物醫(yī)藥類雜志引用近萬次，處于行業(yè)領先水平。NIH、哈佛、耶魯、斯坦福、普林斯頓、杜克大學等約400家全球著名機構使用GenScript的基因合成、多肽服務、抗體服務和蛋白服務等成功地發(fā)表科研成果，再次證明GenScript 有能力幫助業(yè)內科學家Make research easy.

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

Vaccines (Basel). 2023-02; 
Aleksandr V Kudriavtsev, Anna V Vakhrusheva, Nickolay A Kryuchkov, Maria E Frolova, Konstantin A Blagodatskikh, Taras V Ivanishin, Milana Djonovic, Ekaterina A Romanovskaya-Romanko, Anton N Kovalenko, Dmitry A Lioznov, Tatiana G Zubkova, Svetlana V Teplykh, Rodion A Oseshnyuk, Marina A Stukova, Artur A Isaev, Igor V Krasilnikov
Products/Services Used Details Operation
Proteins, Expression, Isolation and Analysis … ) (GenScript, Piscataway, New Jersey, US) that was used in this study. There is a good correlation between PRNT values and the binding inhibition values obtained with GenScript’s … Get A Quote

摘要

關鍵詞

Betuvax-CoV-2, COVID-19, SARS-CoV-2, betulin, clinical trial, subunit vaccine
Article Link > 
      

        

              
主站蜘蛛池模板：
界首市|
南城县|
拜泉县|
富源县|
色达县|
儋州市|
普定县|
奈曼旗|
东宁县|
兴义市|
望谟县|
乐都县|
湘潭市|
清水河县|
赤城县|
韶关市|
额济纳旗|
偏关县|
凉城县|
新密市|
瓮安县|
平阴县|
吴川市|
西丰县|
花垣县|
文登市|
峨边|
环江|
旬阳县|
镇赉县|
阿鲁科尔沁旗|
商城县|
乳山市|
布尔津县|
康保县|
耒阳市|
古交市|
鲁甸县|
禹城市|
武山县|
宁夏|